AltMed Florida to Open the First Medical Cannabis Dispensary in Wellington

AltMed Wellington Grand Opening

Patients in the Wellington Florida region will have access to the award-winning MÜV™ medical cannabis products in a modern, open-concept retail experience starting February 16

Wellington, Fla. – Feb.11, 2019 – AltMed Florida has announced the grand opening of its first southeast Florida MÜV™ Medical Cannabis Dispensary at 1045 South State Road 7, Suite 200, Wellington, FL 33414 in the ‘Wellington Reserve’ medical complex. 

Near Palm Beach International Airport and a short drive from West Palm Beach, Lake Worth, Delray Beach and Boca Raton, the state-of-the-art dispensary is ideally positioned along the rapidly growing I-95 corridor and is the only southeast Florida dispensary west of the Florida Turnpike.  

The Grand Opening is Saturday, February 16, 2019, with a ribbon cutting ceremony at 9:45am. The dispensary opens for business at 10am for licensed Florida medical cannabis patients. Patients will receive 25% off their entire first purchase and the first 100 patients will also receive a MÜV SWAG bag.  

Like AltMed Florida’s three current MÜV Dispensary locations (Tampa, Sarasota and Apollo Beach), the new Wellington dispensary will stand out because it’s designed as a premium experience. Think Apple store, with modern, open-concept design and expert staff with extensive training. Patients can also see real-time, strain specific inventory at where they can order for express pickup or delivery within a 25-mile range.

“Our dispensaries have set the standard for quality products, service and overall patient experience on the Gulf Coast and we are excited to bring our premium MÜV medical cannabis brand to South Florida where there’s high demand from a rapidly growing patient base,” said AltMed Florida CEO John Tipton. “Our dispensaries are unlike anything in the state and we invite all licensed patients to visit our new Wellington location.”

 The MÜV brand already has a wide following in other legal medical cannabis markets, including Arizona, where it has won five Best of Arizona medical cannabis awards.

MÜV products offer an extensive variety of delivery options and formulations, including several that are unique among current Florida license holders with its patent-pending transdermal gels and metered dose inhalers. Products come in a variety of delivery methods and formulations within each delivery method to assure every patient has a product to meet their desired outcome.  Product categories include cannabis flower vaporizer cups, topicals (pain relief cream), 72-hour transdermal patches, metered dose inhalers, distillate vaporizer pens (without any cutting agents), strain specific vaporizer pens, oral sprays, tinctures, capsules as well as the widest selection of strain specific concentrates in the state of Florida. 

MÜV products are sold exclusively in Florida at MÜV dispensaries because, unlike other states, Florida does not allow wholesale of product between license holders – only products that license holders make themselves can be sold in their dispensaries.

“The MÜV retail experience speaks to the role of medical cannabis products in the modern healthcare marketplace,” said AltMed Marketing Director Todd Beckwith. “We learned that MÜV customers in other legal medical cannabis states are more apt to take an active role in their healthcare than with traditional medicine. They want to understand the products and the research behind the products, so we have created a layered and informative retail experience.”

For more information about the new ADA compliant Wellington MÜV Medical Cannabis Dispensary, including hours and available MÜV products, visit: AltMed Florida is on pace to open 30 MÜV Medical Cannabis Dispensaries across the state, all supplied by its 150,000 sq-ft state-of-the-art cultivation facility. Visit this link for images of AltMed Florida’s cultivation operations. For a corporate video see

About AltMed Enterprises – Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.

About AltMed Florida, LLC (Plants of Ruskin, LLC d.b.a.) – With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.

About MÜV™ – The MÜV brand of cannabis infused products was launched in Arizona in 2016 and quickly gained international attention and recognition. In its first six months alone, MÜV received four best of Arizona medical cannabis awards, including two first prizes for its proprietary Ethanol extractions that are the basis of all MÜV products.

Forward-Looking Statements – To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.

Media contact: Colin Trethewey – / 813.480.1354

SOURCE: AltMed Florida